LNSR LENSAR, Inc. - Common Stock
NASDAQ · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 13, 2026
$6.75
· % 处于52周区间
· 高于低点
· 至高点
$4.9552周低点
$12.8452周高点
市值 (MRQ)
$83M
P/E (TTM)
-22.5
EPS (TTM)
$-0.30
收入 (TTM)
$60M
LNSR 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$6.75
市值 (MRQ)
$83M
P/E (TTM)
-22.5
EPS (TTM)
$-0.30
收入 (TTM)
$60M
ROE (TTM)
-851.7%
52周区间
$5–$13
LNSR 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$58M2019-12-31 → 2025-12-31
EPS$-2.872021-12-31 → 2025-12-31
自由现金流·2020-12-31 → 2023-12-31
净利率57.6%2020-12-31 → 2023-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | LNSR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -22.55年均值 ≈-2.9 | ≈-2.9 | · | · | |
| P/S (TTM) | 1.45年均值 ≈1.3 | ≈1.3 | 2.1 | 低估 | |
| 市净率 (MRQ) | 5.65年均值 ≈1.1 | ≈1.1 | 2.7 | 估值过高 | |
| 市净率（有形资产） (MRQ) | 8.25年均值 ≈1.5 | ≈1.5 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | LNSR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -13.5%5年均值 ≈-47.7% | ≈-47.7% | -39.8% | 顶尖 | |
| 净利润率 (TTM) | 57.6%5年均值 ≈-49.1% | ≈-49.1% | -44.3% | 顶尖 | |
| ROA (TTM) | 49.6%5年均值 ≈-27.5% | ≈-27.5% | -43.4% | 持平 | |
| ROE (TTM) | -851.7%5年均值 ≈-41.1% | ≈-41.1% | -41.2% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | LNSR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 2.45年均值 ≈4.0 | ≈4.0 | 3.8 | 低流动性 | |
| 速动比率 (MRQ) | 1.05年均值 ≈2.8 | ≈2.8 | 3.2 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | LNSR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 9.2%5年均值 ≈17.7% | ≈17.7% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 18.2%5年均值 ≈17.0% | ≈17.0% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 17.2% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | LNSR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$389.6K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-393.8%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 13, 2026 | $0.10 | $-0.17 | 159.4% |
| 2026年3月31日 | $0.00 | $0.19 | -100.0% | |
| 2025年12月31日 | $-0.12 | $-0.07 | -68.1% | |
| 2025年9月30日 | $-0.31 | $-0.05 | -507.8% | |
| 2025年6月30日 | $-0.15 | $-0.08 | -96.1% | |
| 2025年3月31日 | $-2.32 | $-0.16 | -1367.4% | |
| 2024年12月31日 | $-1.61 | $-0.18 | -776.9% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $58M | $53M | $42M | $35M | $34M | $26M | $31M | |
| Cost of Revenue | $31M | $28M | $21M | $15M | $17M | $12M | $17M | |
| R&D Expense | $6M | $5M | $6M | $12M | $12M | $8M | $8M | |
| SG&A Expense | $45M | $26M | $26M | $27M | $24M | $24M | $17M | |
| Operating Income | $-25M | $-11M | $-12M | $-20M | $-20M | $-19M | $-13M | |
| Interest Expense | · | · | · | · | · | $1M | $2M | |
| Other Non-op | $636.0K | $660.0K | $698.0K | $263.0K | $51.0K | $68.0K | $58.0K | |
| Pretax Income | $-34M | $-31M | $-14M | $-20M | $-20M | $-20M | $-15M | |
| Net Income | $-34M | $-31M | $-14M | $-20M | $-20M | $-20M | $-15M | |
| EPS (Basic) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | · | · | |
| EPS (Diluted) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | · | · | |
| Shares (Basic) | 11,958,000 | 11,518,000 | 10,971,000 | 10,159,000 | 9,374,000 | · | · | |
| Shares (Diluted) | 11,958,000 | 11,518,000 | 10,971,000 | 10,159,000 | 9,374,000 | · | · | |
| EBITDA | · | · | $-12M | $-20M | $-20M | $-19M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $16M | $21M | $15M | $32M | $41M | $5M | |
| Short-term Investments | $5M | $6M | $3M | · | · | · | · | |
| Receivables | $6M | $6M | $4M | $6M | $5M | $2M | $3M | |
| Inventory | $22M | $11M | $16M | $12M | $6M | $13M | $8M | |
| Prepaid Expense | $601.0K | $2M | $2M | $1M | $2M | $2M | $618.0K | |
| Current Assets | $47M | $42M | $46M | $34M | $45M | $58M | $17M | |
| PP&E (Net) | $505.0K | $664.0K | $679.0K | $563.0K | $756.0K | $832.0K | $720.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | $5M | $6M | $11M | $12M | $11M | $12M | $13M | |
| Other Non-current Assets | $3M | $3M | $2M | $3M | $3M | $4M | $1M | |
| Total Assets | $71M | $66M | $70M | $56M | $66M | $79M | $35M | |
| Accounts Payable | $19M | $6M | $4M | $5M | $3M | $2M | $2M | |
| Accrued Liabilities | $8M | $7M | $6M | $5M | $5M | $5M | $5M | |
| Current Liabilities | $41M | $15M | $12M | $11M | $9M | $8M | $8M | |
| Capital Leases | $2M | $2M | $2M | $2M | $3M | $3M | $333.0K | |
| Other Non-current Liabilities | $909.0K | $702.0K | $570.0K | $167.0K | $69.0K | $129.0K | $310.0K | |
| Total Liabilities | $84M | $48M | $22M | $14M | $12M | $12M | $65M | |
| Common Stock | $120.0K | $116.0K | $113.0K | $111.0K | $110.0K | $109.0K | $11.0K | |
| Retained Earnings | $-178M | $-143M | $-112M | $-98M | $-78M | $-58M | $-38M | |
| AOCI | $4.0K | $6.0K | $4.0K | · | · | · | · | |
| Stockholders' Equity | $-26M | $5M | $33M | $42M | $55M | $67M | $-31M | |
| Liabilities + Equity | $71M | $66M | $70M | $56M | $66M | $79M | $35M | |
| Shares Outstanding | 11,993,000 | 11,654,000 | 11,327,000 | 11,093,000 | 10,990,000 | 10,933,000 | 1,070,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $3M | $6M | $7M | $7M | $9M | $102.0K | |
| Amort. of Intangibles | $921.0K | $970.0K | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-15M | $-2M | $-10M | $-15M | $-9M | $-14M | $-13M | |
| CapEx | $83.0K | $156.0K | $236.0K | $115.0K | $354.0K | $366.0K | $389.0K | |
| Investing Cash Flow | $1M | $-2M | $-4M | $-115.0K | $-354.0K | $-326.0K | $-2M | |
| Stock Issued | · | · | · | · | · | $16M | · | |
| Net Stock Activity | · | · | · | · | · | $16M | · | |
| Financing Cash Flow | $10M | $78.0K | $20M | $-2M | $361.0K | $50M | $16M | |
| Net Change in Cash | $-3M | $-4M | $6M | $-17M | $-9M | $36M | $1M | |
| Taxes Paid | $42.0K | $24.0K | $18.0K | $3.0K | $19.0K | · | · | |
| Free Cash Flow | · | · | $-10M | $-15M | $-9M | $-14M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -29.0% | -57.1% | -57.0% | -70.1% | · | |
| Net Margin | · | · | -34.1% | -56.3% | -56.9% | -75.0% | · | |
| Pretax Margin | · | · | -34.1% | -56.3% | -56.9% | -75.0% | · | |
| EBITDA Margin | · | · | -29.0% | -57.1% | -57.0% | -70.1% | · | |
| ROA | · | · | -22.9% | -32.6% | -26.9% | -34.8% | · | |
| ROE | · | · | -41.2% | -47.1% | -35.0% | -29.0% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 4.0 | 3.0 | 5.1 | 6.9 | · | |
| Quick Ratio | · | · | 2.4 | 1.8 | 4.2 | 5.0 | · | |
| Interest Coverage | · | · | · | · | · | -13.8 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.7 | 0.6 | 0.5 | 0.5 | · | |
| Inventory Turnover | · | · | 1.5 | 1.7 | 1.7 | 1.1 | · | |
| Receivables Turnover | · | · | 8.4 | 6.6 | 10.4 | 9.8 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $2.95 | $3.78 | $4.99 | $6.15 | · | |
| Revenue / Share | · | · | $3.84 | $3.48 | · | · | · | |
| Cash Flow / Share | · | · | $-0.88 | $-1.46 | · | · | · | |
| Cash / Share | · | · | $1.82 | $1.32 | $2.88 | $3.71 | · | |
| EPS (TTM) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.2% | 26.9% | 19.2% | 2.6% | 30.6% | · | · | |
| Revenue CAGR 3Y | 18.2% | 15.8% | 16.9% | · | · | · | · | |
| Revenue CAGR 5Y | 17.2% | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $58M | $53M | $42M | $35M | $34M | $26M | · | |
| Net Income TTM | $-34M | $-31M | $-14M | $-20M | $-20M | $-20M | · | |
| Market Cap | · | · | $40M | $33M | $66M | $79M | · | |
| P/E | -4.1 | -3.3 | -2.7 | -1.5 | -2.9 | · | · | |
| P/S | · | · | 0.9 | 0.9 | 1.9 | 3.0 | · | |
| P/B | · | · | 1.2 | 0.8 | 1.2 | 1.2 | · | |
| P / Tangible Book | · | · | 1.8 | 1.1 | 1.5 | 1.4 | · | |
| P / Cash Flow | · | · | -4.1 | -2.2 | -7.3 | -5.7 | · | |
| P / FCF | · | · | -4.0 | -2.2 | -7.1 | -5.6 | · | |
| Earnings Yield | -24.7% | -30.5% | -37.3% | -66.2% | -34.9% | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $13M | $16M | $14M | $14M | $14M | $17M | $14M | $13M | $11M | $12M | $10M | $12M | $8M | $10M | $8M | |
| Cost of Revenue | $7M | $7M | $9M | $8M | $7M | $7M | $10M | $7M | $6M | $5M | $7M | $5M | $5M | $4M | $4M | $4M | |
| R&D Expense | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | |
| SG&A Expense | $6M | $3M | $10M | $12M | $12M | $11M | $7M | $6M | $7M | $7M | $6M | $5M | $8M | $7M | $7M | $6M | |
| Operating Income | $2M | $2M | $-5M | $-8M | $-6M | $-6M | $-1M | $-1M | $-5M | $-3M | $-3M | $-2M | $-3M | $-4M | $-3M | $-4M | |
| Other Non-op | $171.0K | $145.0K | $151.0K | $133.0K | $193.0K | $159.0K | $149.0K | $153.0K | $160.0K | $198.0K | $233.0K | $265.0K | $111.0K | $89.0K | $123.0K | $92.0K | |
| Income Tax | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income | $4M | $36M | $-1M | $-4M | $-2M | $-27M | $-19M | $-2M | $-9M | $-2M | $-4M | $3M | $-9M | $-4M | $-2M | $-4M | |
| EPS (Basic) | $0.14 | $1.56 | $-0.09 | $-0.31 | $-0.15 | $-2.32 | $-1.62 | $-0.13 | $-0.79 | $-0.19 | $-0.23 | $0.13 | $-0.81 | $-0.40 | $-0.23 | $-0.39 | |
| EPS (Diluted) | $0.10 | $0.00 | $-0.09 | $-0.31 | $-0.15 | $-2.32 | $-1.62 | $-0.13 | $-0.79 | $-0.19 | $0.13 | $-0.23 | $-0.81 | $-0.40 | $-0.23 | $-0.39 | |
| Shares (Basic) | 12,297,000 | 12,161,000 | · | 12,044,000 | 11,937,000 | 11,774,000 | · | 11,604,000 | 11,451,000 | 11,387,000 | · | 11,102,000 | 10,820,000 | 10,716,000 | · | 10,225,000 | |
| Shares (Diluted) | 23,027,000 | 15,420,000 | · | 12,044,000 | 11,937,000 | 11,774,000 | · | 11,604,000 | 11,451,000 | 11,387,000 | · | 11,956,000 | 10,820,000 | 10,716,000 | · | 10,225,000 | |
| EBITDA | $2M | $2M | · | $-8M | $-6M | $-6M | · | $-1M | $-5M | $-3M | · | $-2M | $-3M | $-4M | · | $-4M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $14M | $12M | $13M | $8M | $7M | $20M | $16M | $10M | $8M | $14M | $21M | $25M | $25M | $8M | $15M | $19M | |
| Short-term Investments | $0 | $1M | $5M | $9M | $13M | $6M | $6M | $8M | $6M | $4M | $3M | · | · | · | · | · | |
| Receivables | $6M | $5M | $6M | $6M | $5M | $7M | $6M | $4M | $6M | $4M | $4M | $4M | $3M | $5M | $6M | $4M | |
| Inventory | $25M | $23M | $22M | $21M | $19M | $15M | $11M | $15M | $18M | $18M | $16M | $17M | $18M | $16M | $12M | $8M | |
| Prepaid Expense | $2M | $625.0K | $601.0K | $776.0K | $991.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $47M | $42M | $47M | $44M | $46M | $49M | $42M | $39M | $40M | $42M | $46M | $49M | $49M | $30M | $34M | $32M | |
| PP&E (Net) | $445.0K | $457.0K | $505.0K | $555.0K | $609.0K | $577.0K | $664.0K | $677.0K | $716.0K | $747.0K | $679.0K | $482.0K | $605.0K | $520.0K | $563.0K | $639.0K | |
| PP&E (Gross) | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $11M | $11M | $11M | $12M | $12M | $12M | $12M | |
| Other Non-current Assets | $2M | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| Total Assets | $70M | $66M | $71M | $70M | $70M | $73M | $66M | $62M | $61M | $66M | $70M | $71M | $71M | $52M | $56M | $55M | |
| Accounts Payable | $11M | $10M | $19M | $15M | $11M | $8M | $6M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | |
| Accrued Liabilities | $5M | $4M | $8M | $8M | $6M | $7M | $7M | $6M | $4M | $4M | $6M | $5M | $4M | $3M | $5M | $5M | |
| Current Liabilities | $20M | $18M | $41M | $36M | $30M | $27M | $15M | $12M | $10M | $10M | $12M | $11M | $11M | $10M | $11M | $10M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Liabilities | $874.0K | $815.0K | $909.0K | $911.0K | $544.0K | $616.0K | $702.0K | $205.0K | $262.0K | $537.0K | $570.0K | $560.0K | $568.0K | $360.0K | $167.0K | $22.0K | |
| Total Liabilities | $41M | $42M | $84M | $82M | $80M | $81M | $48M | $25M | $24M | $21M | $22M | $21M | $25M | $13M | $14M | $12M | |
| Common Stock | $123.0K | $121.0K | $120.0K | $119.0K | $119.0K | $118.0K | $116.0K | $116.0K | $115.0K | $114.0K | $113.0K | $112.0K | $112.0K | $111.0K | $111.0K | $110.0K | |
| Retained Earnings | $-138M | $-141M | $-178M | $-176M | $-172M | $-171M | $-143M | $-125M | $-123M | $-114M | $-112M | $-108M | $-111M | $-102M | $-98M | $-95M | |
| AOCI | $0 | $0 | $4.0K | $5.0K | $-3.0K | $3.0K | $6.0K | $15.0K | $-6.0K | $-1.0K | $4.0K | · | · | · | · | · | |
| Stockholders' Equity | $15M | $11M | $-26M | $-26M | $-23M | $-22M | $5M | $23M | $24M | $32M | $33M | $36M | $33M | $39M | $42M | $43M | |
| Liabilities + Equity | $70M | $66M | $71M | $70M | $70M | $73M | $66M | $62M | $61M | $66M | $70M | $71M | $71M | $52M | $56M | $55M | |
| Shares Outstanding | 12,282,000 | 12,101,000 | 11,993,000 | 11,935,000 | 11,933,000 | 11,790,000 | 11,654,000 | 11,612,000 | 11,544,000 | 11,395,000 | 11,327,000 | 11,246,000 | 11,199,000 | 11,103,000 | 11,093,000 | 11,023,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $347.0K | $690.0K | $873.0K | $850.0K | $766.0K | $654.0K | $662.0K | $668.0K | $683.0K | $652.0K | $816.0K | $1M | $2M | $2M | $2M | $2M | |
| Amort. of Intangibles | $228.0K | $229.0K | $230.0K | $229.0K | $230.0K | $232.0K | $232.0K | $232.0K | $232.0K | $274.0K | $273.0K | $273.0K | $275.0K | $276.0K | $276.0K | $276.0K | |
| Operating Cash Flow | $-127.0K | $-4M | $618.0K | $-4M | $-5M | $-7M | $4M | $3M | $-4M | $-5M | $-480.0K | $-339.0K | $-2M | $-7M | $-5M | $-5M | |
| CapEx | · | · | $0 | $0 | $77.0K | $6.0K | $3.0K | $20.0K | $113.0K | $20.0K | $45.0K | $2.0K | $181.0K | $8.0K | $57.0K | $2.0K | |
| Investing Cash Flow | $965.0K | $4M | $4M | $4M | $-7M | $531.0K | $2M | $-905.0K | $-2M | $-1M | $-4M | $-2.0K | $-181.0K | $-8.0K | $-57.0K | $-2.0K | |
| Financing Cash Flow | $233.0K | $-209.0K | $474.0K | $0 | $93.0K | $10M | $172.0K | $-93.0K | $129.0K | $-130.0K | $146.0K | $-205.0K | · | · | $196.0K | $-1M | |
| Net Change in Cash | $1M | $-480.0K | $5M | $487.0K | $-12M | $3M | $6M | $2M | $-6M | $-7M | $-4M | $-546.0K | $17M | $-7M | $-5M | $-6M | |
| Taxes Paid | · | · | $0 | · | · | · | $2.0K | $0 | · | · | $0 | $0 | $17.0K | $1.0K | $-7.0K | $0 | |
| Free Cash Flow | · | · | · | · | · | $-7M | · | · | · | $-5M | · | · | · | $-7M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.9% | 16.7% | · | -52.9% | -45.1% | -40.9% | · | -9.2% | -41.8% | -26.9% | · | -20.8% | -23.9% | -52.8% | · | -52.7% | |
| Net Margin | 21.4% | 270.6% | · | -25.9% | -12.7% | -193.1% | · | -11.1% | -71.6% | -20.4% | · | 26.2% | -72.9% | -51.8% | · | -51.5% | |
| EBITDA Margin | 12.9% | 16.7% | · | -52.9% | -45.1% | -40.9% | · | -9.2% | -41.8% | -26.9% | · | -20.8% | -23.9% | -52.8% | · | -52.7% | |
| ROA | 5.1% | 52.2% | · | -5.6% | -2.7% | -39.3% | · | -2.3% | -13.6% | -3.6% | · | 4.1% | -13.5% | -7.6% | · | -6.5% | |
| ROE | -86.8% | -640.2% | · | 234.3% | -594.9% | -564.2% | · | -5.1% | -32.1% | -6.0% | · | 6.5% | -22.6% | -9.6% | · | -8.0% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.4 | · | 1.2 | 1.5 | 1.8 | · | 3.4 | 3.9 | 4.1 | · | 4.4 | 4.7 | 3.0 | · | 3.3 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.6 | 0.8 | 1.2 | · | 1.9 | 1.9 | 2.1 | · | 2.6 | 2.7 | 1.3 | · | 2.3 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.0 | 2.3 | · | 2.8 | 2.6 | 2.6 | · | 3.3 | 2.8 | 2.4 | · | 2.6 | 4.0 | 2.0 | · | 2.4 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.21 | $0.89 | · | $-2.17 | $-1.93 | $-1.88 | · | $1.96 | $2.05 | $2.79 | · | $3.24 | $2.92 | $3.55 | · | $3.86 | |
| Revenue / Share | $0.72 | $0.87 | · | $1.19 | $1.17 | $1.20 | · | $1.17 | $1.10 | $0.93 | · | $0.82 | $1.11 | $0.77 | · | $0.76 | |
| Cash Flow / Share | · | $-0.28 | · | · | · | $-0.59 | · | · | · | $-0.47 | · | · | · | $-0.62 | · | · | |
| Cash / Share | $1.10 | $1.03 | · | $0.64 | $0.60 | $1.66 | · | $0.90 | $0.72 | $1.22 | · | $2.22 | $2.27 | $0.72 | · | $1.75 | |
| EPS (TTM) | $-0.30 | $-0.55 | · | $-4.40 | $-4.22 | $-4.86 | · | $-0.98 | $-1.08 | $-1.10 | · | $-1.67 | $-1.83 | $-1.69 | · | $-2.13 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $60M | $58M | · | $59M | $58M | $57M | · | $49M | $45M | $44M | · | $40M | $38M | $34M | · | $36M | |
| Net Income TTM | $35M | $29M | · | $-52M | $-49M | $-57M | · | $-17M | $-13M | $-12M | · | $-13M | $-20M | $-18M | · | $-21M | |
| Market Cap | $70M | $72M | · | $147M | $157M | $166M | · | $53M | $52M | $39M | · | $35M | $48M | $28M | · | $61M | |
| P/E | -19.0 | -10.8 | · | -2.8 | -3.1 | -2.9 | · | -4.7 | -4.2 | -3.1 | · | -1.9 | -2.3 | -1.5 | · | -2.6 | |
| P/S | 1.2 | 1.2 | · | 2.5 | 2.7 | 2.9 | · | 1.1 | 1.2 | 0.9 | · | 0.9 | 1.2 | 0.8 | · | 1.7 | |
| P/B | 4.7 | 6.7 | · | -5.7 | -6.8 | -7.5 | · | 2.3 | 2.2 | 1.2 | · | 1.0 | 1.5 | 0.7 | · | 1.4 | |
| P / Tangible Book | 6.9 | 12.4 | · | · | · | · | · | 3.2 | 3.0 | 1.8 | · | 1.4 | 2.3 | 1.0 | · | 2.0 | |
| P / Cash Flow | · | -16.9 | · | · | · | -24.0 | · | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| Earnings Yield | -5.2% | -9.2% | · | -35.6% | -32.0% | -34.4% | · | -21.4% | -24.0% | -32.4% | · | -54.0% | -43.1% | -67.9% | · | -38.4% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $58M | $53M | $42M | $35M | $34M |
| 营业利润率 % | · | · | -29.0% | -57.1% | -57.0% |
| 净收入 | $-34M | $-31M | $-14M | $-20M | $-20M |
| 稀释后每股收益 (EPS) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | · | · | 4.0 | 3.0 | 5.1 |
| 速动比率 | · | · | 2.4 | 1.8 | 4.2 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | · | · | $-10M | $-15M | $-9M |
机构持有人 (13F) 81 家申报者 · $31.0M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
81
持有价值
$31.0M
新仓位
18
已退出持仓
29
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 18 (-8 与上一季度对比) | 29 (+20 与上一季度对比) | 19 (-12 与上一季度对比) | 20 (+5 与上一季度对比) | -831K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | $6140534 | 1075400 | 19.80% | 股份 |
| VANGUARD GROUP INC | $5997881 | 515725 | 19.34% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $2300022 | 402806 | 7.42% | 股份 |
| Groupe la Francaise | $1219296 | 213537 | 3.93% | 股份 |
| RBF Capital, LLC | $1077254 | 188661 | 3.47% | 股份 |
| BlackRock, Inc. | $1056539 | 185033 | 3.41% | 股份 |
| CSS LLC/IL | $933300 | 163450 | 3.01% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $865687 | 151609 | 2.79% | 股份 |
| CREDIT INDUSTRIEL ET COMMERCIAL | $824290 | 144359 | 2.66% | 股份 |
| Kerrisdale Advisers, LLC | $795917 | 139390 | 2.57% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $689083 | 120680 | 2.22% | 股份 |
| DCF Advisers, LLC | $675019 | 118217 | 2.18% | 股份 |
| Evernest Financial Advisors, LLC | $674351 | 118100 | 2.17% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $653221 | 114331 | 2.11% | 股份 |
| UBS Group AG | $488970 | 85634 | 1.58% | 股份 |
| Yakira Capital Management, Inc. | $475574 | 83288 | 1.53% | 股份 |
| STATE STREET CORP | $462413 | 80983 | 1.49% | 股份 |
| Man Group plc | $445164 | 77962 | 1.44% | 股份 |
| Alpine Global Management, LLC | $340139 | 59569 | 1.10% | 股份 |
| GOLDMAN SACHS GROUP INC | $339911 | 59529 | 1.10% | 股份 |
| GABELLI FUNDS LLC | $336890 | 59000 | 1.09% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $330215 | 57831 | 1.07% | 股份 |
| Dynamic Technology Lab Private Ltd | $309000 | 54166 | 1.00% | 股份 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $304103 | 53258 | 0.98% | 股份 |
| Centiva Capital, LP | $281229 | 49252 | 0.91% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $252696 | 44255 | 0.81% | 股份 |
| CITADEL ADVISORS LLC | $204115 | 35747 | 0.66% | 股份 |
| CITADEL ADVISORS LLC | $203276 | 35600 | 0.66% | 卖出期权 |
| GAMCO INVESTORS, INC. ET AL | $188430 | 33000 | 0.61% | 股份 |
| LPL Financial LLC | $180824 | 31668 | 0.58% | 股份 |
| Quinn Opportunity Partners LLC | $167583 | 29349 | 0.54% | 股份 |
| GTS SECURITIES LLC | $142773 | 25004 | 0.46% | 股份 |
| Cresset Asset Management, LLC | $142750 | 25000 | 0.46% | 股份 |
| ROYAL BANK OF CANADA | $134000 | 23464 | 0.43% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $133169 | 23322 | 0.43% | 股份 |
| NORTHERN TRUST CORP | $125717 | 22017 | 0.41% | 股份 |
| JANE STREET GROUP, LLC | $116273 | 20363 | 0.38% | 股份 |
| Carlson Capital, L.P. | $114200 | 20000 | 0.37% | 股份 |
| Qube Research & Technologies Ltd | $106052 | 18573 | 0.34% | 股份 |
| Sanctuary Advisors, LLC | $95911 | 16797 | 0.31% | 股份 |
| Atria Investments, Inc | $86695 | 15183 | 0.28% | 股份 |
| Murchinson Ltd. | $75503 | 13223 | 0.24% | 股份 |
| Engineers Gate Manager LP | $63324 | 11090 | 0.20% | 股份 |
| JANE STREET GROUP, LLC | $62810 | 11000 | 0.20% | 买入期权 |
| &PARTNERS | $60263 | 10554 | 0.19% | 股份 |
| Bank of New York Mellon Corp | $57606 | 10089 | 0.19% | 股份 |
| Skandinaviska Enskilda Banken AB (publ) | $57100 | 10000 | 0.18% | 股份 |
| Russell Investments Group, Ltd. | $56204 | 9843 | 0.18% | 股份 |
| MORGAN STANLEY | $48491 | 8492 | 0.16% | 股份 |
| FMR LLC | $18209 | 3189 | 0.06% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| North Run Capital, LP, North Run Advisors, LLC, NR-GRI Partners, LP, NR-GRI Partners GP, LP, ELLIS THOMAS B, HAMMER TODD B ×2 申报 | 2025年3月25日 | 55.90% | 修订 | 并购/出售 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 13 位内幕人士 · 4 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Nicholas T Curtis | Chief Executive Officer | 2026年6月3日 A | 1122758 | 0 | 0 | $0 |
| Thomas R Staab II | Chief Financial Officer | 2026年5月6日 F | 174609 | 0 | 0 | $0 |
| Alan B. Connaughton | Chief Operating Officer | 2026年6月3日 A | 389173 | 0 | 0 | $0 |
| Kendra Wong | Principal Accounting Officer | 2026年6月3日 A | 56481 | 0 | 0 | $0 |
| Gary M Winer | 董事 | 2026年6月3日 A | 105635 | 0 | 0 | $0 |
| Elizabeth G. O'Farrell | 董事 | 2026年6月3日 A | 67368 | 0 | 0 | $0 |
| HAMMER TODD B | 董事 | 2026年6月3日 A | 56083 | 0 | 0 | $0 |
| Thomas B Ellis | 董事 | 2026年6月3日 A | 56083 | 0 | 0 | $0 |
| Richard L Lindstrom MD | 董事 | 2026年6月3日 A | 263831 | 0 | 0 | $0 |
| William J Link PHD | 董事 | 2026年6月3日 A | 568062 | 0 | 0 | $0 |
| Aimee S Weisner | 董事 | 2026年6月3日 A | 110368 | 0 | 0 | $0 |
| John Peter Mclaughlin | 董事 | 2023年5月25日 A | 53631 | 0 | 0 | $0 |
| PDL BIOPHARMA, INC. | 10% 所有者 | 2020年10月1日 J | 0 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 5 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
LNSR 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 8 位分析师
买入
中位数目标
$11.00
+63.0%
3 37.5%
强烈买入
4 50.0%
买入
1 12.5%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
3 位分析师 · 2026-10-03平均目标 $11.33 +67.9%
← 低于所有目标
当前价格 $6.75
最低$10.00
平均值$11.33
最高$13.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| LNSR | · | -4.1 | 9.2% | · | · | · |
| ECOR | $36M | -2.7 | 27.2% | -43.6% | 4686.6% | 86.8% |
| HYPR | · | -2.3 | 5.2% | -262.3% | -93.5% | 49.8% |
| LUNG | $92M | -1.7 | 8.0% | -59.7% | -87.7% | 74.2% |
| MBOT | $134M | -6.9 | · | · | -24.4% | · |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| VANI | $94M | -2.9 | · | · | -257.8% | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 13, 2026 申报